Mitochondrial Thioredoxin Reductase Is Essential for Early Postischemic Myocardial Protection
Author(s) -
Jan Horstkotte,
Tamara Perisic,
Manuela Schneider,
Philipp S. Lange,
Melanie Schroeder,
Claudia Kiermayer,
Rabea Hinkel,
Tilman Ziegler,
Pankaj Kumar Mandal,
Robert David,
Sabine Schulz,
Sabine Schmitt,
Julian D. Widder,
Fred Sinowatz,
Bernhard F. Becker,
Johann Bauersachs,
M Naebauer,
Wolfgang M. Franz,
Irmela Jeremias,
Markus Brielmeier,
Hans Zischka,
Marcus Conrad,
Christian Kupatt
Publication year - 2011
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.111.059253
Subject(s) - mitochondrial permeability transition pore , reactive oxygen species , reperfusion injury , medicine , thioredoxin reductase , oxidative stress , thioredoxin , mitochondrial ros , ischemia , mitochondrion , pharmacology , microbiology and biotechnology , biology , programmed cell death , apoptosis , biochemistry
Excessive formation of reactive oxygen species contributes to tissue injury and functional deterioration after myocardial ischemia/reperfusion. Especially, mitochondrial reactive oxygen species are capable of opening the mitochondrial permeability transition pore, a harmful event in cardiac ischemia/reperfusion. Thioredoxins are key players in the cardiac defense against oxidative stress. Mutations in the mitochondrial thioredoxin reductase (thioredoxin reductase-2, Txnrd2) gene have been recently identified to cause dilated cardiomyopathy in patients. Here, we investigated whether mitochondrial thioredoxin reductase is protective against myocardial ischemia/reperfusion injury.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom